{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:26:16Z","timestamp":1793805976996,"version":"4.6.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["Z220017"],"award-info":[{"award-number":["Z220017"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jocn.2026.112187","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:38:42Z","timestamp":1783751922000},"page":"112187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond response rates: Residual seizure burden and willingness to undergo vagus nerve stimulation again in drug-resistant epilepsy"],"prefix":"10.1016","volume":"152","author":[{"given":"Xinjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jocn.2026.112187_b0005","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia."},{"issue":"16","key":"10.1016\/j.jocn.2026.112187_b0010","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.0b013e3182a393d1","article-title":"Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy","volume":"81","author":"Morris","year":"2013","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.jocn.2026.112187_b0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nec.2018.12.005","article-title":"Vagus nerve stimulation for the treatment of epilepsy","volume":"30","author":"Gonz\u00e1lez","year":"2019","journal-title":"Neurosurg Clin N Am."},{"issue":"2","key":"10.1016\/j.jocn.2026.112187_b0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/WNL.45.2.224","article-title":"A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures","volume":"45","author":"The Vagus Nerve Stimulation Study Group","year":"1995","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.jocn.2026.112187_b0025","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1212\/WNL.51.1.48","article-title":"Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial","volume":"51","author":"Handforth","year":"1998","journal-title":"Neurology."},{"issue":"8","key":"10.1016\/j.jocn.2026.112187_b0030","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1212\/WNL.53.8.1731","article-title":"Vagus Nerve Stimulation Study Group E01\u2013E05. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy","volume":"53","author":"Morris","year":"1999","journal-title":"Neurology."},{"issue":"8","key":"10.1016\/j.jocn.2026.112187_b0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1474-4422(02)00220-X","article-title":"Vagus-nerve stimulation for the treatment of epilepsy","volume":"1","author":"Ben-Menachem","year":"2002","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jocn.2026.112187_b0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejpn.2007.01.008","article-title":"Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study","volume":"11","author":"De Herdt","year":"2007","journal-title":"Eur J Paediatr Neurol."},{"issue":"3","key":"10.1016\/j.jocn.2026.112187_b0045","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1227\/NEU.0000000000001165","article-title":"Rates and predictors of seizure freedom with vagus nerve stimulation for intractable epilepsy","volume":"79","author":"Englot","year":"2016","journal-title":"Neurosurgery."},{"issue":"6","key":"10.1016\/j.jocn.2026.112187_b0050","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/epi.12611","article-title":"The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE trial","volume":"55","author":"Ryvlin","year":"2014","journal-title":"Epilepsia."},{"key":"10.1016\/j.jocn.2026.112187_b0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.yebeh.2016.10.005","article-title":"Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data","volume":"66","author":"Englot","year":"2017","journal-title":"Epilepsy Behav."},{"issue":"2","key":"10.1016\/j.jocn.2026.112187_b0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/epi4.12319","article-title":"Seizure burden in severe early-life epilepsy: perspectives from parents","volume":"4","author":"Berg","year":"2019","journal-title":"Epilepsia Open."},{"key":"10.1016\/j.jocn.2026.112187_b0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.seizure.2020.09.027","article-title":"Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation for epilepsy treatment: A critical review","volume":"83","author":"Toffa","year":"2020","journal-title":"Seizure."},{"issue":"12","key":"10.1016\/j.jocn.2026.112187_b0070","doi-asserted-by":"crossref","first-page":"e3342","DOI":"10.1002\/brb3.3342","article-title":"Usage and impact of patient-reported outcomes in epilepsy","volume":"13","author":"Vonck","year":"2023","journal-title":"Brain Behav."}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826003383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826003383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:29:34Z","timestamp":1793802574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826003383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":14,"alternative-id":["S0967586826003383"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112187","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond response rates: Residual seizure burden and willingness to undergo vagus nerve stimulation again in drug-resistant epilepsy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112187"}}